secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2026-08-12T12:29:46+00:00
Accession:  0001493152-26-037254
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ENvue Medical signs $50M equity facility; amends Series H preferred to add $59M
-------------------------------------------------------------------------------

- Entered $50M committed equity facility; shares sold at 90% of 3-day VWAP.
- 40% of net proceeds to redeem Series X Preferred; remainder for working capital.
- Second Amendment raises Series H Additional Investment Rights to $59M stated value ($53.1M subscription).
- Investor commits to exercise at least $10M in 12 months post-shareholder approval, $833,333.33 monthly minimum.
- Exchange cap of 1,858,403 shares (19.99% of outstanding) unless shareholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315226037254/0001493152-26-037254-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315226037254/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-037254

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer